0

Tazarotene

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP118292403
CAS118292-40-3
Structure
Molecular Weight351.46
Description≥98% (HPLC)
SolubilityDMSO: >15 mg/mL
Assay≥98% (HPLC)
Colorwhite to very faintly yellow
Formpowder
Size10MG, 50MG
Storage Conditions2-8°C
1

Drugs for Psoriasis

Med Lett Drugs Ther. 2019 Jun 17;61(1574):89-96.

PMID: 31381544

1

Pharmacokinetics of Tazarotene and Acitretin in Psoriasis

Michael S Heath, Dev R Sahni, Zachary A Curry, Steven R Feldman

Expert Opin Drug Metab Toxicol. 2018 Sep;14(9):919-927.

PMID: 30134735

1

Psoriasis in Those Planning a Family, Pregnant or Breast-Feeding. The Australasian Psoriasis Collaboration

Marius Rademaker, Karen Agnew, Megan Andrews, Katherine Armour, Chris Baker, Peter Foley, John Frew, Kurt Gebauer, Monisha Gupta, Debra Kennedy, Gillian Marshman, John Sullivan

Australas J Dermatol. 2018 May;59(2):86-100.

PMID: 28543445

1

Topical Therapies in Psoriasis

R Torsekar, Manjyot M Gautam

Indian Dermatol Online J. Jul-Aug 2017;8(4):235-245.

PMID: 28761838

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode